GLP-1 receptor agonists may improve outcomes for patients with morbid obesity after TKA

Results showed patients with a BMI of 40 kg/m2 or more who used glucagon-like peptide-1 receptor agonists for at least 90 days before and after total knee arthroplasty had a decreased risk for postoperative complications vs. controls.

Source: Healio

Read more